BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6800414)

  • 1. Behavioral effects and physiological disposition of some beta-hydroxylated indoleamines in the rat.
    Gentile NT; Friedman HA; Vogel WH
    Biol Psychiatry; 1982 Jan; 17(1):109-13. PubMed ID: 6800414
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1977 Jun; 12(3):339-46. PubMed ID: 266950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
    Commissaris RL; Davis M
    Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
    Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
    Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
    [No Abstract]   [Full Text] [Related]  

  • 5. Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat.
    Seeman G; Brown GM
    Neuropharmacology; 1985 Dec; 24(12):1195-200. PubMed ID: 3867833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance to behavioral effects of N, N-dimethyltryptamine in mice.
    Cooper SG; Schiff SR; Bridger WH
    Biol Psychiatry; 1981 Sep; 16(9):861-7. PubMed ID: 6794656
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat.
    Sitaram BR; Lockett L; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 Jul; 36(13):2235-7. PubMed ID: 3475068
    [No Abstract]   [Full Text] [Related]  

  • 9. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    J Psychiatr Res; 1978; 14(1-4):225-40. PubMed ID: 281530
    [No Abstract]   [Full Text] [Related]  

  • 10. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
    Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
    Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents.
    Quock RM; Lum MH; Small SF
    Proc West Pharmacol Soc; 1979; 22():217-8. PubMed ID: 292978
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 13. [The mechanism of the inhibitory influence of noradrenaline and serotonin on conditioned avoidance reactions in rats].
    Talalaenko AN
    Farmakol Toksikol; 1973; 36(5):517-20. PubMed ID: 4788056
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.
    Schlemmer RF; Narasimhachari N; Thompson VD; Davis JM
    Commun Psychopharmacol; 1977; 1(2):105-18. PubMed ID: 414877
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.
    Sitaram BR; Lockett L; Talomsin R; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 May; 36(9):1509-12. PubMed ID: 3472526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of certain indoleamines in the hippocampal-septal circuit.
    DeFrance JF; McCrea RA; Yoshihara H
    Exp Neurol; 1975 Aug; 48(2):352-77. PubMed ID: 1080118
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior.
    Vasko MR; Lutz MP; Domino EF
    Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1978 Jun; 63(2):380P. PubMed ID: 276408
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the behavioral effects of proteo-and deutero-N, N-dimethyltryptamine.
    Beaton JM; Barker SA; Liu WF
    Pharmacol Biochem Behav; 1982 May; 16(5):811-4. PubMed ID: 6806829
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.
    Smythies JR; Morin RD; Brown GB
    Biol Psychiatry; 1979 Jun; 14(3):549-56. PubMed ID: 289421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.